QuantRx Biomedical Corporation
QuantRx Biomedical Announces Positive Phase I Safety Results for BFPET, Myocardial Perfusion Imaging MPI Tracer for Positron Emission Tomography PET by FluoroPharma
Published in Hospital Law Weekly, August 14th, 2008
QuantRx(R) Biomedical Corporation (OTCBB:QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, announced that QuantRx's FluoroPharma has achieved positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging. BFPET is FluoroPharma's second cardiovascular product to complete Phase I clinical development.
BFPET is a PET imaging agent, designed to assess the blood flow in the heart (myocardial perfusion). Myocardial perfusion imaging is a standard test to assess coronary artery...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-08-14)
More Articles from Hospital Law Weekly
- Cancer
Goshen Center for Cancer Care to present at health care forum for Sen. Bob Dole - CIGNA
CIGNA Enhances Senior Leadership Team - Diabetes
Ortho-McNeil Initiates First-of-Its-Kind Skin Infection Registry To Review Current Treatment Patterns and Identify Potential Gaps - Ekahau Inc.
Madrid Hospital Improves Employee Safety With Ekahau Wi-Fi RTLS - Life Sciences
Researchers at Cincinnati Children's Hospital target life sciences - Life Sciences
Safe Lifting Toolkit Provides Free Resources for Healthcare Injury Prevention - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
